![Amit Munshi](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amit Munshi
Vorsitzender bei
SENSORION
Vermögen: 4 Mio $ am 31.05.2026
Profil
Amit Dilip Munshi founded Oxeia Biopharmaceuticals, Inc. in 2014, where he worked as Director and Kythera Biopharmaceuticals LLC in 2005, where he worked as Chief Business Officer from 2005 to 2011.
Mr. Munshi also founded Johnson & Johnson, where he worked as Chief Business Officer and Nephrian, Inc., where he worked as Director.
Mr. Munshi also currently works at Enterprise Therapeutics Ltd., as Co-Chairman from 2020, Zura Bio Ltd., as Chairman from 2023, Inhibikase Therapeutics, Inc., as Independent Chairman from 2025, and various other companies.
Mr. Munshi also formerly worked at Arena Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2016 to 2022, Percivia LLC, as President & Chief Executive Officer from 2011 to 2012, ReNAgade Therapeutics, Inc., as Chief Executive Officer & Director from 2023 to 2024, and various other companies.
Mr. Munshi received his undergraduate degree from the University of California, Riverside and Masters Business Admin degree from Peter F Drucker & Masatoshi Ito Graduate School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ZURA BIO LIMITED CLASS A 0,82 % | 17.06.2026 | 777.384 ( 0,82 % ) | 3 Mio $ | 31.05.2026 |
| 26.06.2026 | 403.176 ( 0,31 % ) | 705 558 $ | 31.05.2026 | |
| 05.06.2026 | 4.021 ( 0 % ) | 86 291 $ | 31.05.2026 |
Aktuelle Nachrichten zu Amit Munshi
Aktive Positionen von Amit Munshi
| Unternehmen | Position | Beginn |
|---|---|---|
| ZURA BIO LIMITED | Vorsitzender | 01.03.2023 |
| INHIBIKASE THERAPEUTICS, INC. | Vorsitzender | 14.02.2025 |
| SENSORION | Vorsitzender | 01.04.2025 |
| ARCUTIS BIOTHERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 04.12.2025 |
Onebiopharma, Inc.
 Onebiopharma, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Direktor/Vorstandsmitglied | - |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Direktor/Vorstandsmitglied | - |
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Vorsitzender | 01.01.2020 |
Adrista, Inc. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Amit Munshi
| Unternehmen | Position | Ende |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Vorsitzender | - |
| ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Amit Munshi
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
63
Beziehungen ersten Grades
31
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 31 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and commercializes novel dermatology prescription drugs | Health Technology |
LungLife AI, Inc.
 LungLife AI, Inc. Medical SpecialtiesHealth Technology Develops early detection solutions for lung cancer | Health Technology |
Cytrellis Biosystems, Inc.
 Cytrellis Biosystems, Inc. Medical SpecialtiesHealth Technology Designs and develops aesthetic devices | Health Technology |
Oxeia Biopharmaceuticals, Inc.
 Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biotechnology company which develops therapeutics for mild traumatic brain injuries and neuro-metabolic dysfunctions | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Percivia LLC
 Percivia LLC Miscellaneous Commercial ServicesCommercial Services Provides research for developing vaccine and recombinant protein products | Commercial Services |
Iolab Corp. | |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
EPIRUS Biopharmaceuticals, Inc. /Old/
 EPIRUS Biopharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops monoclonal antibodies | Health Technology |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Peter F Drucker & Masatoshi Ito Graduate School of Management
 Peter F Drucker & Masatoshi Ito Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nephrian, Inc. | |
EPIRUS Biopharmaceuticals, Inc.
 EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Health Technology |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Adrista, Inc. | |
Arena Pharmaceuticals GmbH
 Arena Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Onebiopharma, Inc.
Onebiopharma, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
Orna Therapeutics, Inc.
 Orna Therapeutics, Inc. BiotechnologyHealth Technology Develops RNA therapeutics | Health Technology |
Social Capital Suvretta Holdings Corp. IV
 Social Capital Suvretta Holdings Corp. IV Financial ConglomeratesFinance Operates as blank check company | Finance |
JATT Acquisition Corp.
 JATT Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Zura Bio Ltd.
 Zura Bio Ltd. BiotechnologyHealth Technology Operates as a multi-asset clinical-stage biotechnology company that focuses on develops novel medicines for immune and inflammatory disorders | Health Technology |
Renagade Therapeutics, Inc.
 Renagade Therapeutics, Inc. BiotechnologyHealth Technology Develops proprietary delivery technologies to unlock previously inaccessible cells | Health Technology |
Wählen Sie MarketScreener 
